Pharmaceutically useful furyl substituted dihydroxyethylbutyrolactones
US5102909A · kind A · utility
6Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 1990 |
| Grant date | Apr 7, 1992 |
| Priority date | — |
| Expiry date | Jun 11, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4- dihydroxyethylbutyrolactone and 2-(5-methoxymethyl-2- furyl)-2-furyl(-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone and pharmaceutical compositions containing them are useful to regulate the immune response in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.